-
Abstract Number: 1754
Comorbidities and Treatments in United States Youth with Chronic Musculoskeletal Pain
-
Abstract Number: 1755
Improving Adolescent Health Care Transition: Piloting the Transition Readiness Assessment Questionnaire
-
Abstract Number: 1756
Health-related Social Media Use by Parents of Children with Rheumatic Diseases
-
Abstract Number: 1757
Review of Effectiveness of an Intensive Rehabilitation Programme in Managing Strength, Pain and Function in 123 Young People with Rheumatological Conditions
-
Abstract Number: 1758
Development of Ultrasound Detectable Arthritis Among ACPA Positive Subjects with Musculoskeletal Symptoms: The Risk RA Prospective Study
-
Abstract Number: 1759
Methotrexate in Patients with Hand Erosive Osteoarthritis Refractory to Usual Treatments: A Randomized, Double-blind, Placebo-controlled Trial
-
Abstract Number: 1760
Six-week Treatment with Low-dose Prednisolone in Patients with Painful Hand Osteoarthritis (HOPE): Results from a Randomised Double-blind Placebo-controlled Trial
-
Abstract Number: 1761
The Prospective Open Label Preventive Approach to Congenital Heart Block with Hydroxychloroquine (PATCH) Study Demonstrates a Reduction in the Recurrence Rate of Advanced Block
-
Abstract Number: 1762
UV Light Induces Acute Type I Interferon Production in the Skin and Blood Which Is cGAS Dependent
-
Abstract Number: 1763
A Phase 3 Randomized Controlled Trial of Anifrolumab in Patients with Moderate to Severe Systemic Lupus Erythematosus
-
Abstract Number: 1764
CCL25, a Novel Fibroblast and Macrophage Chemoattractant That Potentiates RA Bone Erosion
-
Abstract Number: 1765
Interferon-gamma Supports Transcriptional Activity of BIRC5 in CD4+ T Cells in Established Rheumatoid Arthritis
-
Abstract Number: 1766
GM-CSF Is a Pro-Inflammatory Cytokine in Experimental Vasculitis of Medium and Large Arteries
-
Abstract Number: 1767
Biomarker Profiling Reveals Novel Mechanistic Insights into Ustekinumab Therapeutic Responses in Systemic Lupus Erythematosus
-
Abstract Number: 1768
A First-in-class Selective and Potent IRAK4 Degrader Demonstrates Robust in Vitro and in Vivo Inhibition of TLR/IL-1R Activation and Inflammation
- « Previous Page
- 1
- …
- 118
- 119
- 120
- 121
- 122
- …
- 198
- Next Page »